REQUEST – FCF LIFE SCIENCES RESEARCH SERIES
FCF Life Sciences engages in research on recent financing trends in the Life Sciences sector, i.e. biotechnology, pharma and med-tech. FCF primarily focuses on the latest activities in the equity capital markets: Venture Capital, Initial Public Offerings (IPO) and Equity Valuations.
The findings are regularly published in
NEWS & PRESS
FCF Biotech Venture Capital Monitor – USA 12/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 12/2020”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Life Sciences Venture Capital Monitor – Europe 11/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 11/2020”. The Monitor is a monthly published overview of venture capital trends in the European Life
FCF Biotech Public Equity Monitor – November 2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Public Equity Monitor – November 2020”. The Biotech Public Equity Monitor, part of FCF Life Sciences Research Series, is the most detailed
Dr. Axel Polack becomes the latest expert to join the Life Sciences Advisory Board at FCF Fox Corporate Finance GmbH
The Munich-based corporate financing specialist welcomes yet another highly regarded authority to its Life Sciences Advisory Board. Munich, December 15, 2020 The newest member of the Life Sciences Advisory Board at FCF Fox Corporate Finance
FCF Biotech Venture Capital Monitor – USA 11/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 11/2020”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As